Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cejinzhan Oral Ulcer Patch in Recurrent Aphthous Ulcer
CTR20131733Phase 3Active
- Sponsor
- Shandong Institute of Pharmaceutical Industry
- Start
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Cejinzhan in aphthosis (RAS), sponsored by Shandong Institute of Pharmaceutical Industry. Started Sep 2015; status: active.
02
Drugs
Cejinzhan
03
Conditions
aphthosis (RAS)
Beyond the preview
Go deeper on CTR20131733.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131733.